Stimulating epilepsy

External trigeminal nerve stimulation is a new treatment in epilepsy for when drugs are not effective or when resective surgical options are not an option.

Dr Slaght has received consulting fees from Biogen Idec, Genzyme, Teva and Novartis. Dr Slaght has received travel support from Teva, Novartis, Genzyme, Biogen Idec, National Multiple Sclerosis Society and MS Research Australia. Dr Slaght has received grant support from the National Multiple Sclerosis Society, Genzyme, Takeda and Roche.